简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
IPO application lapsed
SIMCERE ZAIMING HKEX Listing Application Lapses Upon Six-Month Expiry; Recorded Most Out-Licensing Transactions Among Chinese Biopharma Firms in 2025
Tags:
SIMCERE ZAIMING
IPO
IPO application lapsed
2026-07-09
JIWUSIWEI HKEX Listing Application Lapses Upon Six-Month Expiry; Ranked No.1 Among China’s Gastropub Brands for Three Consecutive Years 2022–2024
Tags:
JIWUSIWEI
IPO
IPO application lapsed
2026-07-09
SUNNY & SANDY HKEX Listing Application Expires After Six Months; Ranked 2nd Largest Domestic Player in China’s Licensed Toy & IP Solution Industry
Tags:
SUNNY & SANDY
IPO
IPO application lapsed
2026-07-08
XIZI HEALTH HKEX Listing Application Expires After Six Months; Ranks 3rd Among Domestic Sports Nutrition Food Brand Operators
Tags:
Xizi Health
IPO
IPO application lapsed
2026-07-08
BIORAY BIOPHARM HKEX IPO Application Lapsed Upon Expiry, a Leading Fully Integrated Biopharmaceutical Company in China
Tags:
BIORAY BIOPHARM
IPO
IPO application lapsed
2026-07-06
New Shicoh HKEX IPO Application Lapsed Upon Expiry, a Globally Leading Manufacturer of Micro Precision Motors
Tags:
New Shicoh Motor
IPO
IPO application lapsed
2026-07-03
Leadrive Technology (SHANGHAI) Co., Ltd. HKEX IPO Application Lapsed Upon Expiry, Ranking No.1 in Main Drive Power Brick Market
Tags:
Leadrive Technology
IPO
IPO application lapsed
2026-07-03
LIANJI TECH HKEX GEM IPO Application Lapsed Upon Expiry, Specialising in Industrial Park Property Management
Tags:
Lianji Tech
IPO
IPO application lapsed
2026-07-03
Pinecone Wisdom Inc. HKEX IPO Application Lapsed Upon Expiry; Leading Shared E-Bike Service Provider in China
Tags:
Pinecone
IPO
IPO application lapsed
2026-07-03
EpimAb Biotherapeutics Inc.’s HKEX IPO Application Lapsed, Dual Antibody Pipeline Centered on EGFR/cMET
Tags:
EpimAb Bio
IPO
IPO application lapsed
2026-06-18
COREE’s HKEX IPO Application Lapsed, China’s Largest Paediatric Pharmaceutical Marketing & Promotion Service Provider
Tags:
COREE
IPO
IPO application lapsed
2026-06-18
Kingsware: No. 1 in China’s AI Digital Employee Solutions for 3 Consecutive Years; Hong Kong IPO Application Lapses
Tags:
Kingsware
IPO
IPO application lapsed
2026-06-15
Aulton New Energy’s Hong Kong IPO Application Lapsed, China’s Largest Independent Third-Party Battery Swap Solution Provider
Tags:
Aulton New Energy
IPO
IPO application lapsed
2026-06-12
CSPC Innovation Pharmaceutical’s HK IPO Application Lapses, World’s Largest Synthetic Caffeine Producer
Tags:
CSPC Innovation Pharma
IPO
IPO application lapsed
2026-06-11
Trunk Technology’s HKEX IPO Application Lapses, China’s Largest L4 Autonomous Truck Provider for Closed Road Scenarios
Tags:
Trunk Technology
IPO
IPO application lapsed
2026-06-11
Marubi's HK IPO Application Lapses, Ranks 3rd in China's Recombinant Collagen Skincare Segment
Tags:
Marubi
IPO
IPO application lapsed
2026-06-11
Youcare Pharmaceutical’s HKEX IPO Application Lapses; Focused on Novel Modalities Including Oligonucleotide and mRNA Therapies
Tags:
Youcare Pharma
IPO
IPO application lapsed
2026-06-05
Hand Enterprise Solutions’ HK IPO Application Lapses; Ranked Top Domestic Player in China’s Corporate IT Consulting & Digital Solution Sector
Tags:
Hand Enterprise
IPO
IPO application lapsed
2026-06-05
Mandi Inc.’s HKEX IPO Application Lapsed; Its Brand Products Rank No.1 in China’s Anti-hair Loss Drug Market for Ten Consecutive Years
Tags:
Mandi Inc.
IPO
IPO application lapsed
minoxidil
2026-05-21
HLA's Hong Kong IPO Lapses, Global No.2 Men's Wear Brand's Listing Dream Temporarily Shelved
Tags:
HLA Group
600398.SH
IPO application lapsed
2026-05-21
Previous
1
2
3
4
5
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App